Stocks · News reference

GRI Bio Says FDA Grants Orphan Drug Designation To GRI-0621 For Treatment Of Idiopathic Pulmonary Fibrosis, Irreversible And Ultimately Fatal Lung Disease

Jun 18, 2026, 12:34 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 24, 2026, 2:36 PMBenzinga Newsdesk
GRI Bio shares are trading higher after the company announced three abstracts and an oral presentation highlighting data from the Phase 2a GRI-0621-IPF-02 study have been selected for presentation at ERS Congress 2026.
Read original at benzinga
GRI
BenzingaAug 11, 2026, 5:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings
Read original at benzinga
ACB AIXC ALMR CRIS GRI
SEC EDGARJun 18, 2026, 8:50 PMSEC EDGAR
8-K filing — GRI Bio, Inc. (GRI)
Filed: 2026-06-18 AccNo: 0001824293-26-000050 Size: 248 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgar
GRI